RIBOXINUM-DARNITSA

Anabolic drug that has antihypoxic and antiarrhythmic action

learn more

RIBOXINUM-DARNITSA

Anabolic drug that has antihypoxic and antiarrhythmic action

The drug normalizes myocardial contractile activity and stimulates complete myocardial relaxation in diastole through the ability to bind calcium ions that penetrated cells during stimulation, activates tissue regeneration.

Indications for use:

  • combined therapy of coronary heart disease
  • arrhythmia;
  • intoxication with cardiac glycosides;
  • treatment of cardiomyopathies of various genesis, myocardiodystrophy, myocarditis;
  • liver disease;
  • prevention of leucopoenia under radiation therapy; to improve visual function in open-angle glaucoma with normalized intraocular pressure.
More in instructions (Ukrainian version)
INN
Inosine
Package
20 mg/ml,10 x 10 ml
Form of release
Solution for injection
АТС class
C01E B

See also

Specialized publications intended for medical institutions and doctors Limitations in obtaining information